Stricter inspections of Chinese vaccine manufacturers have caused a shortage of flu vaccines, raised the risks of widespread infections and highlighted the lack of staff at the country’s top pharmaceutical regulator.
針對中國疫苗制造商的更嚴格檢查導致流感疫苗短缺,增加了大面積感染的風險,并突顯出中國最高醫藥監管機構人手不足。
您已閱讀6%(271字),剩余94%(4214字)包含更多重要信息,訂閱以繼續探索完整內容,并享受更多專屬服務。